Northern Trust’s Cyteir Therapeutics, Inc. Common Stock CYT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-68,283
| Closed | -$208K | – | 4512 |
|
|
2023
Q4 | $208K | Buy |
68,283
+34,094
| +100% | +$104K | ﹤0.01% | 3889 |
|
|
2023
Q3 | $97.1K | Buy |
34,189
+15,205
| +80% | +$43.2K | ﹤0.01% | 4022 |
|
|
2023
Q2 | $49.4K | Hold |
18,984
| – | – | ﹤0.01% | 4224 |
|
|
2023
Q1 | $34.6K | Buy |
18,984
+4,077
| +27% | +$7.42K | ﹤0.01% | 4348 |
|
|
2022
Q4 | $24.6K | Buy |
14,907
+1,732
| +13% | +$2.86K | ﹤0.01% | 4442 |
|
|
2022
Q3 | $25K | Hold |
13,175
| – | – | ﹤0.01% | 4512 |
|
|
2022
Q2 | $39K | Sell |
13,175
-125,069
| -90% | -$370K | ﹤0.01% | 4476 |
|
|
2022
Q1 | $521K | Buy |
138,244
+65,819
| +91% | +$248K | ﹤0.01% | 3724 |
|
|
2021
Q4 | $823K | Sell |
72,425
-758
| -1% | -$8.61K | ﹤0.01% | 3617 |
|
|
2021
Q3 | $1.28M | Buy |
+73,183
| New | +$1.28M | ﹤0.01% | 3471 |
|